Evidence map›Paper›PMID 31885423›Full record

ArticleWorld journal of gastroenterology2019

MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma.

He-Ying Zhou, Chun-Qi Wu, En-Xu Bi

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. MiR-96-5p Facilitates Lung Adenocarcinoma Cell Phenotypes by Inhibiting FHL1.Computational and mathematical methods in medicine · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

He-Ying ZhouDepartment of General Surgery, Jinan Seventh People's Hospital, Jinan 251400, Shandong Province, China.
Chun-Qi WuDepartment of General Surgery, Jinan Seventh People's Hospital, Jinan 251400, Shandong Province, China.
En-Xu BiDepartment of General Surgery, Qingdao West Coast New Area Central Hospital, Qingdao 266555, Shandong Province, China. biepinqiang71@163.com.
Fourth People’s Hospital of Jinan · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric adenocarcinoma (GAC) mortality rates have remained relatively changed over the past 30 years, and it continues to be one of the leading causes of cancer-related death.

aimTo search for novel miRNAs related to GAC prognosis and further investigate the effect of miR-96-5p on MGC-803 cells.

methodsThe miRNA expression profile data of GAC based on The Cancer Genome Atlas were obtained and used to screen differently expressed miRNAs (DEMs) and DEMs related to GAC prognosis. Then, the expression of DEMs related to GAC prognosis was identified in GAC tumor samples and adjacent normal samples by qRT-PCR. The target gene,

resultsA total of 299 DEMs and 35 DEMs related to GAC prognosis were screened based on The Cancer Genome Atlas. Then compared with adjacent normal samples, the levels of miR-96-5p, miR-222-5p, and miR-652-5p were remarkably increased, while miR-125-5p, miR-145-3p, and miR-379-3p levels were reduced in GAC tumor samples (

conclusionOur findings identified six miRNAs related to GAC prognosis and suggested that downregulated miR-96-5p might induce cell apoptosis

Indexed as

Gene Expression Regulation, NeoplasticAcyltransferasesAdenocarcinomaAgedApoptosisCell Line, TumorComputational BiologyDown-RegulationFemaleGastrectomyGene Expression ProfilingHumansMaleMicroRNAsMiddle AgedPrognosisAcyltransferasesMicroRNAsMIRN96 microRNA, humanZDHHC5 protein, humanCell apoptosisDifferently expressed miRNAsGastric adenocarcinomaMicroRNA-96-5pPrognosisThe Cancer Genome Atlas

Identifiers

PMID31885423
PMCPMC6931005
OpenAlexW2996265266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.